ABSTRACT: Introduction: We sought to translate, cross-culturally adapt, and evaluate the internal consistency and validity of the Chinese version of the 15-Item Myasthenia Gravis Quality of Life (MG-QOL15). Methods: Translation and cross-cultural adaptation of the MG-QOL15 were performed. We used Cronbach's α to test internal consistency, one-way analysis of variance to test construct validity, and Pearson or Spearman correlations to test discriminant and concurrent validity. Results: We enrolled 168 outpatients. Internal consistency was excellent (Cronbach's α = 0.928). The MG-QOL15 discriminated MG severity as stratified by the MG Composite (MGC; P < 0.001) and Osserman class (P = 0.01). Concurrent validity was low to moderate with the subscales of the 36-item Short Form (−0.31 to $−0.59), MGC (r = 0.46), and Myasthenia Gravis Activities of Daily Living profile (r = 0.54). Discussion: The Chinese MG-QOL15 showed comparable construct, discriminant and concurrent validity, and internal consistency with to the original version.
mune disease in which an antibody-mediated blockade of neuromuscular transmission results in fluctuating muscle weakness. 1 Research has shown that patients' social life, job, and mood are significantly affected. 2, 3 Previous studies [4] [5] [6] [7] [8] [9] [10] [11] [12] have confirmed these findings regarding physical and psychological aspects of MG patients' health-related quality of life (HRQOL). The 36-item short form of the Medical Outcomes Study Health Survey (SF-36) is a generic instrument assessing QOL and is widely used in patients with MG. However, it lacks specificity for patients with MG. 4, 6 In 2008, Mullins et al. 5 produced a specific scalethe 60-item Myasthenia Gravis Quality Of Life questionnaire (MG-QOL60)-to assess HRQOL for Patients with MG. The 15-item Myasthenia Gravis Quality Of Life questionnaire (MG-QOL15) was developed by Burns et al. 13 by simplifying the MG-QOL60. The MG-QOL15 is composed of 9 items concerning mobility, 3 items concerning symptoms, 2 items concerning emotional well being, and 1 item concerning general contentment. It uses 5 response options ("not at all" to "very much"), and the total score ranges from 0 to 60. Higher MG-QOL15 scores indicate worse QOL. The MG-QOL15 has been successfully translated and validated in Japanese, Persian, Italian, Turkish, Brazilian, Dutch and French. [14] [15] [16] [17] [18] [19] [20] The objective of our study was to produce a Chinese (all references to Chinese language are to Mandarin Chinese) version of the MG-QOL15 and assess its internal consistency and validity.
MATERIALS AND METHODS
Patients. Patients with MG were consecutively enrolled from the Outpatient Department of Neurology, West China Hospital, Sichuan University from October 2015 to September 2016. Patient enrollment satisfied the following inclusion criteria. First, the diagnosis was made by a neurologist according to 2015 Chinese guidelines for the diagnosis and treatment of patients with MG. 21 According to the guidelines, there are 5 criteria: (1) clinical findings of fluctuating symptoms, muscle fatigability, and recovery after rest; (2) symptom improvement with anticholinesterase; (3) abnormal repetitive nerve stimulation testing (decrement > 10%); (4) presence of antibodies against the acetylcholine receptor or muscle-specific tyrosine kinase receptor; (5) exclusion of other diseases. Patients who meet the first, the fifth, and at least 1 of the second or third criteria could receive a diagnosis of MG. The fourth criterion is not essential. Second, patients had a disease duration of >1 month and were in a stable state. We defined "stable" as the patient not having experienced acute phase progression or an MG crisis during the preceding 4 weeks. Patients were excluded if they were unable to complete the questionnaires because of a lack of Chinese fluency or cognitive impairment determined by a team member. Patients with other severe diseases (e.g., myocardial infarction or malignant tumor) that might confound the HRQOL measures were also excluded. Informed consent was obtained from each participant, and our study was approved by the West China Hospital Institutional Review Board and Ethics Committee.
Data Collection. All data were collected during the clinical visit. Sex, age, marital status, educational level, employee status, and disease duration were documented by the doctor. Osserman class 22 and MG Composite (MGC) scores 23 were evaluated by the same neurologist on the day of consultation.
The Myasthenia Gravis Activities of Daily Living (MG-ADL) profile [24] [25] [26] was completed by patients. The MGC consists of 10 questions, with total scores ranging from 0 to 50, and higher MGC scores indicate worse clinical status. 23 The MG-ADL consists of 8 items, and the total score ranges from 0 to 24. Higher MG-ADL scores indicate worse clinical status. 24 In addition to the Chinese MG-QOL15, the Chinese SF-36 was also completed by patients with MG. The Chinese SF-36 is reliable, valid, and widely used. [27] [28] [29] There are 8 subscales, each with scores ranging from 0 to 100, and higher scores indicate better QOL.
Translation and Cross-Cultural Adaptation of the MG-QOL15. The MG-QOL15 was translated into Chinese and cross-culturally adapted according to published international guidelines. 30 There were 8 steps.
(1) Preparation: We recruited 6 specialists (5 neurologists and 1 linguist). All 5 doctors were experienced in treating MG and were proficient in English. (2) Statistical Analysis. We determined the sample size with the method of subject-to-item ratio. 31 The subject-to-item ratio was required to be equal to or greater than 5 32, 33 ; thus, the sample size should be greater than 75. Continuous data are reported as mean AE SD, and categorical variables are reported as frequencies or percentages. Correlations between 2 variables were assessed by using Pearson's correlation when the data fit bivariate normal distribution or Spearman's correlation when the data did not fit bivariate normal distribution. A correlation coefficient of 0.7-0.9 was defined as a high correlation, 0.5-0.7 was defined as moderate, and 0.3-0.5 was defined as low. 34 Data analysis was performed in SPSS for Windows version 20.0 (IBM, Armonk, New York). The threshold for statistical significance was set at P < 0.05.
Internal Consistency Reliability. We evaluated the internal consistency of the MG-QOL15 with Cronbach's α coefficient as well as item-total and inter-item correlations. An α of 0.9 was taken to represent excellent internal consistency, 0.8 was considered good, and 0.7 was considered acceptable. 17 The scale had good reliability when item-total and interitem correlations were both >0.40. 15 Validity. Validity was tested in 3 ways. First, construct validity was evaluated by testing differences in MG-QOL15 scores among patients sorted by the MGC scores (≤4, 5-11, and ≥12) by using one-way analysis of variance (ANOVA) with post hoc tests (Holm Bonferroni). 15, 17 The Holm Bonferroni corrected P value for significance was 0.0167 (0.05/3). We also tested the difference in MG-QOL15 scores between Osserman class I and II/III groups with ANOVA. Second, discriminant validity was tested by comparing the correlations between the SF-36 (physical composite summary score [PCS] and mental composite score [MCS] ) and the MG-QOL15 with the correlations between the SF-36 and severity scores (MGC and MG-ADL). Pearson or Spearman correlations were used. Third, concurrent validity 17 was evaluated by correlating the MG-QOL15 scores with the 8 subscales of the SF-36 by using Pearson or Spearman correlations. Corrections were made for multiple comparisons. The corrected P value for significance was 0.00625 (0.05/8). We also correlated the MG-QOL15 with severity scores (MGC and MG-ADL) by using Spearman correlations.
RESULTS
Patient Characteristics. In total, 168 MG outpatients (98 women; mean age of all participants 38.7 AE 14.9 years) were enrolled. Patient characteristics are displayed in Table 1 .
Translation. The MG-QOL15 was successfully translated into Chinese. The structure of the original American version was retained. In the forward translation step, differences referring to the words frustrated (item 1) and overwhelmed (item 14) were discussed and resolved. Item 10 (driving) was reworded as personal independence (e.g., driving, biking, shopping, and running errands) in cognitive debriefing because some patients had no driving licenses or did not drive.
Internal Consistency Reliability. The internal consistency of the MG-QOL15 was excellent (Cronbach's α = 0.928; Table 2 ). When the item was excluded, the Cronbach's α coefficient was consistently ≤ 0.928, except for items 2 (0.929) and 10 (0.929), but did not substantially increase with removal. The average inter-item correlation was 0.47, and item-total correlation ranged between 0.54 and 0.85.
Validity. There were significant differences in MG-QOL15 scores among patients with different MGC scores or Osserman class (Table 3) . Post hoc analysis showed that MG-QOL15 scores were significantly lower in the MGC ≤ 4 (range, 0-46; 13.4 AE 10.1) subgroup than in either the 5 ≤ MGC ≤ 11 (range, 0-58; 24.0 AE 14.1) or the MGC ≥ 12 (range, 10-50; 26.6 AE 12.9) groups. Table 4 displays r values for tests of discriminant validity. Moderate negative correlations were observed between the SF-36 (PCS and MCS) and the Chinese MG-QOL15. All correlations between the SF-36 (PCS and MCS) and MGC scores and MG-ADL were low. Table 5 displays concurrent validity data. Moderate correlations were found between the Chinese MG-QOL15 and MG-ADL and 4 of the SF-36 subscales (P < 0.001). The MGC and the other SF-36 subscales had low correlations with MG-QOL15 (P < 0.001).
DISCUSSION
The MG-QOL15 was translated into Chinese with success and proved to be reliable and valid. Item 10 was reworded, but no other major problems were encountered in the translation and cultural adaptation process. Similarly to previous versions, [14] [15] [16] [17] the Chinese MG-QOL15 exhibited excellent internal consistency and good validity.
The overall Cronbach's α coefficient of the Chinese MG-QOL15 (0.928) was similar to the other versions (0.890-0.958). [13] [14] [15] [16] [17] 20 Similarly to the original American version, 13 item-total correlations of the Chinese MGQOL-15 were notably high for the items "I have limited my social activity because of my condition" (0.85) and "I have trouble meeting the needs of my family" (0.82). Correlations were lowest for bulbar symptoms, (e.g., "speaking" [0.54]). The correlation for the item "I have trouble using my eyes" (0.54) was also notably low, probably because of vision changes from other etiologies that lacked disease specificity. 35 The results of construct validity suggested that the Chinese MG-QOL15 functions well in recognizing the impact of different MGC scores and Osserman class on QOL, as previously reported. 5, 15, 17 MGC, Myasthenia Gravis Composite; MG-QOL15, 15-item Myasthenia Gravis Quality-of-Life.
*P < 0.05, **P < 0.01, ***P < 0.0167 (the Holm Bonferroni P-value required for significance was 0.05/3 = 0.0167). In our study, the correlations between the Chinese MG-QOL15 and SF-36 subscales were similar to those found in the original version and the other versions. 13, 16, 17 We conclude with Burns et al. 13 that the MG-QOL15 has a good balance of content and no superfluous information. Just as in the original version, the Chinese MG-QOL15 captures what it was designed to assess. 13 The MG-QOL15 and MGC scores could both reflect the variation in disease severity. Therefore, the correlations between the MG-QOL15 and MGC scores would not be expected to change. However, similarly to the Italian version, the correlation between the Chinese MG-QOL15 and MGC score was slightly lower than for the original American version (0.46 vs. 0.67). 36 No obvious convincing explanation was available for this difference except the speculation by Raggi and colleagues 15 that this was probably caused by an unequal distribution of MGC among our patients with MG. In our study, patients with MGC ≤ 4 accounted for 62.5% of patients, and those with MGC ≥ 12 accounted for 11.3% of patients, which was similar to the study by Raggi et al. 15 However, the corresponding values in the study by Burns et al. 36 were 38.9% and 25.1%, respectively.
The current study had several limitations. In our cohort, we excluded patients with other severe diseases that could confound HRQOL. Severe diseases were defined according to the guidelines for the use of disease definition for severe disease insurance, drafted by the Chinese Medical Doctor Association. However, enrolled patients may have other mild medical illnesses. Such a confounding factor probably would cause a low correlation between MG-QOL15 and SF-36 scores. In addition, we did not perform retests, so data on test-retest reliability are lacking. Similarly to the other versions (0.890-0.958), the Chinese MG-QOL15 had excellent internal consistency (Cronbach's α = 0.928). However, the coefficient was greater than the maximum α recommended of 0.90, indicating that there may be redundant questions in the Chinese MG-QOL15, although our translation mirrors the original scale. 37 This point was not discussed in the previous versions. [14] [15] [16] [17] These limitations must be addressed in future studies.
In conclusion, we translated and culturally adapted the MG-QOL15 questionnaire to create a Chinese version according to standard guidelines. Our study found that the Chinese version of the MG-QOL15 was comparable to the original version in internal consistency and in construct, discriminant, and concurrent validity.
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